E-cadherin and its cytoplasmic partners, catenins, mediate epithelial cell-cell adhesion. Disruption of this adhesion allows cancer cells to invade and metastasize. Aberrant activation of the Src tyrosine kinase disrupts cell-cell contacts through an E-cadherin/catenin-dependent mechanism. Previously we showed that Rack1 regulates the growth of colon cells by suppressing Src activity at G 1 and mitotic checkpoints, and in the intrinsic apoptotic and Akt cell survival pathways. Here we show that Rack1, partly by inhibiting Src, promotes cell-cell adhesion and reduces the invasive potential of colon cancer cells. Rack1 stabilizes E-cadherin and catenins at cell-cell contacts by inhibiting the Src phosphorylation of E-cadherin, the ubiquitination of E-cadherin by the E3 ligase Hakai and the endocytosis of E-cadherin. Upon depletion and restoration of extracellular calcium, Rack1 facilitates the re-assembly of E-cadherin-containing cell-cell contacts. Rack1 also blocks HGF-induced endocytosis of E-cadherin, disruption of cell-cell contacts and cell scatter. Our results uncover a novel function of Rack1 in maintaining the junctional homeostasis of intestinal epithelial cells by regulation of the Src-and growth factor-induced endocytosis of E-cadherin.
Introduction
The dynamic regulation of cell-cell adhesion is crucial for developmental processes, including cell motility, differentiation, cell fate decisions and tissue morphogenesis. Epithelial cell-cell contacts comprise the adherens junctions (AJs), tight junctions, desmosomal junctions and gap junctions, reinforced by the actin cytoskeleton. Maintenance of junctional homeostasis and normal tissue architecture is a result of tight regulation of signaling networks, which impinge directly or indirectly on the junctional components. E-cadherin is an important constituent of AJs and in association with its cytoplasmic partners, the catenins, mediates homophilic cell-cell adhesion, which signals for contact inhibition of growth. E-cadherin thus functions as a tumor suppressor and, indeed, progression of epithelial tumors frequently involves the destabilization of cellcell adhesion, a consequence of mislocalization, mutation or loss of expression of E-cadherin and its associated catenins (Gumbiner, 2005; Hartsock and Nelson, 2008; Jeanes et al., 2008; Berx and van Roy, 2009) .
Multiple mechanisms that regulate the availability of E-cadherin for the formation of cell-cell junctions have been proposed in recent years. A focal event in determining the stability of junctional E-cadherin appears to be the endocytosis and routing of 'internalized' E-cadherin to the degradation-versus-recycling pathway. The choice of pathway is dictated by the nature of growth factor stimulation and signaling pathways activated within the cell. These processes are fine-tuned and facilitate junctional remodeling during normal physiological processes such as wound healing (Bryant and Stow, 2004; Kowalczyk and Reynolds, 2004; Yap et al., 2007; Delva and Kowalczyk, 2009; Schill and Anderson, 2009 ). The homeostasis is however disrupted in pathological states, including cancer, and could result from excessive signaling by growth factors such as epidermal growth factor, transforming growth factor-b, hepatocyte growth factor (HGF) or aberrant activation of non-receptor tyrosine kinases like Src (Lu et al., 2003; Janda et al., 2006; Mosesson et al., 2008; Shen et al., 2008; Orlichenko et al., 2009; Saitoh et al., 2009) . For instance, Src regulates various facets of signaling to AJs as well as E-cadherin stability, and is a key contributor to epithelial-mesenchymal transition, which drives tumor metastasis (Frame, 2004; Yeatman, 2004) . Src has been shown to phosphorylate E-cadherin and catenins. Tyrosine phosphorylation of E-cadherin by Src targets it for ubiquitination-dependent endocytosis and degradation, thus limiting its availability at cell-cell contacts (Behrens et al., 1993; Fujita et al., 2002; Palacios et al., 2005) . Tyrosine phosphorylation of other AJ-localized Src substrates such as the Rho-GEF, Tiam1, also contributes to the disruption of AJs in human malignancies (Woodcock et al., 2009) .
Src is important for relaying integrin adhesion signals through focal adhesion kinase (FAK) to disrupt E-cadherin-dependent cell-cell contacts in colon cancer cells (Avizienyte et al., 2002 (Avizienyte et al., , 2004 Avizienyte and Frame, 2005) . Similarly, deregulated activation of the HGF receptor tyrosine kinase c-Met has been causally implicated in epithelial-mesenchymal transition during tumor progression and metastasis owing to its multipotent effects on both integrin-mediated adhesion and E-cadherin dependent cell-cell adhesion (Lai et al., 2009) . Epithelial-mesenchymal transition has significant consequences for neoplastic progression, patient survival and therapeutic resistance of cancers. Targeting of critical proteins such as Src and c-Met in the epithelialmesenchymal transition signaling cascade represents a promising strategy for controlling the metastatic spread of epithelial cancers (Wadhawan et al., 2010) . Identification of regulatory factors that modulate oncogenic pathways, such as those that are mediated by Src, will bring forth new, efficient therapies to fight cancer progression and drug resistance.
The adaptor protein Rack1 is an important regulator of biological functions, including cell growth, migration, protein translation and apoptosis. Previously we identified Rack1 as a novel substrate and inhibitor of Src (Chang et al., 1998 (Chang et al., , 2001 (Chang et al., , 2002 . We showed that Rack1 regulates the growth of cells by inhibiting Src activity at G 1 and mitotic cell-cycle checkpoints and cell survival pathways (Mamidipudi et al., 2004 (Mamidipudi et al., , 2007 Mamidipudi and Cartwright, 2009 ). Rack1 also functions in protein kinase-C, insulin growth factor receptor and integrin signaling pathways (Schechtman and Mochly-Rosen, 2001; McCahill et al., 2002; Cox et al., 2003; Kiely et al., 2005; Doan and Huttenlocher, 2007; Vomastek et al., 2007) . Rack1 was shown recently to form a 'direction-sensing' complex with FAK and PDE4D5 phosphodiesterase to facilitate directional migration (Serrels et al., 2010) .
While the role of Rack1 in integrin-mediated cell adhesion has been studied extensively, the function of Rack1 in E-cadherin-mediated cell-cell adhesion is poorly understood and the effect of Rack1 on Src signaling at cell-cell contacts is unknown. We hypothesized that Rack1 promotes cell-cell adhesion by inhibiting the Src phosphorylation of E-cadherin and thereby interfering with the ubiquitination of E-cadherin by Hakai and the endocytic targeting of E-cadherin to lysosomes for degradation. We thought that Rack1 might also promote the re-cycling of internalized E-cadherin to the cell surface, facilitate the re-assembly of cell-cell contacts and reduce the invasive potential of colon carcinoma cells.
We show that Rack1 promotes cell-cell adhesion by stabilizing E-cadherin and catenins at the cell-cell junctions. Rack1 suppresses the tyrosine phosphorylation of E-cadherin and catenins, and consequent ubiquitination-dependent endocytosis of E-cadherin, in part by inhibiting Src activity. Rack1 opposes AJ disassembly and importantly, reduces the invasive potential of colon cancer cells. In addition, Rack1 blocks HGF-mediated Ecadherin endocytosis and the resultant cell scattering. Collectively, our results suggest that Rack1 is involved in the maintenance of junctional homeostasis in intestinal epithelial cells by regulation of the Src-and growth factorinduced endocytosis of E-cadherin.
Results
Rack1 promotes epithelial cell-cell adhesion and inhibits cell invasion, partly by suppressing Src activity We hypothesized that Rack1 promotes epithelial cellcell adhesion, partly by restraining Src kinase activity. To test this, we first expressed green fluorescence protein (GFP)-Rack1 stably in HT-29 colon carcinoma cells. We chose HT-29 cells for these studies because we showed that Src-specific activity is elevated in the cells and can be suppressed by overexpression of Rack1 or by incubating the cells with cell-permeable peptides that enhance Rack1's interaction with Src (Mamidipudi et al., 2007) . We also showed that Rack1 regulates the growth of these cells by suppressing Src activity at G 1 and mitotic checkpoints, and in the intrinsic apoptotic and Akt cell survival pathways (Mamidipudi et al., 2007; Mamidipudi and Cartwright, 2009) . Others showed that increased Src activity in HT-29 cells disrupts E-cadherin adhesion as a result of aberrant tyrosine phosphorylation of the E-cadherin/catenin complex (Skoudy et al., 1996) . Thus, Rack1's influence on Src activity and Src's influence on E-cadherin function have been studied extensively in these cells.
To distinguish the Src-dependent and Src-independent mechanisms of Rack1 function, we expressed a Rack1 mutant that we generated (Rack1 Y228F/Y246F) that lacked the Src phosphorylation and binding sites, and consequently was no longer a substrate, binding partner or inhibitor of Src (Chang et al., 2001 (Chang et al., , 2002 Mamidipudi et al., 2004) .
We generated HT-29 cell lines stably expressing a GFP-tagged vector, wild-type Rack1 (wtRk) or mutant Y228/246F Rack1 (mRk). Multiple clones (8 wtRk, 7 mRk and 9 vector clones) were purified by limiting dilution and characterized. Rack1-GFP expression was confirmed by immunoblotting of cell lysates using Rack1 or GFP antibodies ( Figure 1a and Supplementary Figure 1 ). Two representative clones expressing the vector (vG2 and vG2.2), wtRk (wtG5 and wtF2.2) or mRk (mH11 and mH8) were chosen for subsequent experiments and similar results were obtained with both clones.
To examine Rack1's influence on cell-cell adhesion, we performed 'hanging-drop assays' to measure cell aggregation. The experiments were performed in the presence or absence of EDTA, which chelates calcium essential for cadherin clustering during the formation of cell-cell contacts. In the absence of EDTA, the wtRkexpressing cells formed compact, cohesive clusters of cells that were not disrupted following vigorous pipetting, indicating strong cell-cell adhesion (Figure 1b , column-2, row-2). By contrast, the cell clusters formed by the control cells were smaller and dispersed easily following pipetting (column-1, row-2). The mRk-expressing cells formed clusters, but smaller than those formed by the wtRk1-expressing cells (column-3, row-2). Rack1-induced cell aggregation was dependent on the presence of calcium in the medium (lower panels). Quantitation of the data confirmed that wild-type, and to a lesser extent mutant Rack1-expressing cells, formed larger, more cohesive cell aggregates than the control cells (Table 1 ). The wtRk-expressing cells induced the formation of clusters with an area 410 5 pixel units, containing 41700 cells, whereas the control cells formed smaller clusters. These results show that Rack1 promotes calcium-dependent epithelial cell-cell adhesion, partly by regulating Src activity.
Dissolution of cell-cell junctions in transformed epithelial cells allows the cells to invade through the underlying basement membrane and spread to distant sites. We hypothesized that by promoting cell-cell adhesion, Rack1 would reduce the invasive potential of colon carcinoma cells. To test this, we first analyzed HT-29 cells stably expressing Rack1 for their ability to invade through matrigel and migrate toward a chemoattractant ( Figure 1c ). We observed that only half as many wtRk-expressing cells invaded through the matrigel as the control cells. The ability of the mRk-expressing cells to invade was intermediate to that of the wtRk-and the vector-expressing cells. Consistent with Rack1 overexpression inhibiting invasion, Rack1 depletion in HT-29 cells by 80-90% resulted in a 40% increase in invasion as compared with the control cells (Figure 1d , left panels).
To determine whether Rack1 regulates the invasion of colon cancer cells other than HT-29, we depleted Rack1 in WiDr colon carcinoma cells and assessed the effect on matrigel invasion (Figure 1d , right panels). The inhibitory effect of Rack1 on the Src activity in WiDr cells has been reported in previous studies from our laboratory (Mamidipudi et al., 2007) . Similar to results obtained in HT-29 cells, depletion of Rack1 resulted in a twofold increase in the invasion of WiDr cells. Collectively, our results show that, there are both Src-dependent and Srcindependent mechanisms by which Rack1 regulates cellcell adhesion and invasion of human colon cancer cells. Lysate protein (25 mg) from single-cell clones was subjected to immunoblot analysis using antibodies that recognize Rack1 (36 kDa) or GFP (27 kDa). The data shown are representative of three or more independent experiments from two representative clones of vec (G2, G2.2), wtRk (G5, F2.2) and mRk (H11, H8) that were analyzed. (b) Effect of Rack1 on cell aggregation. Rack1À or vector transfectants were cultured in the presence or absence of EDTA and analyzed by phase-contrast microscopy before and after tituration with a pipette. The data shown are representative fields from three independent experiments performed on each of three clones of vector (G2, G6, G2.2) and wtRk (G5, H9, F2.2), and two clones of mRk (H8, H11). (c) Effect of Rack1 on invasion of cells through matrigel. A total of 3 Â 10 4 cells were seeded onto matrigel-coated filters, incubated for 48 h and cells on the undersurface of the filter were stained and counted, as described under Materials and methods. The data shown are representative of two clones each of the vector (G2, G2.2), wtRk (G5, F2.2) and mRk (H11, H8) transfectants analyzed. The data from the Rack1 transfectants are expressed relative to those for the vector transfectants and represent the mean values ± standard errors from three independent experiments. (d) Effect of Rack1 depletion on invasion of colon cancer cells. HT-29 and WiDr colon cancer cells transfected with a non-targeting siRNA (ctrl si) or a Rack1 siRNA (Rk si) were harvested 72 h later and subjected to immunoblot analysis using anti-Rack1 or a-tubulin as indicated (upper panels), or analyzed for invasion through matrigel as outlined in panel c (lower graphs). The data shown for the invasion assays represent the mean values ±standard errors from four independent experiments.
Rack1 promotes epithelial cell-cell adhesion G Swaminathan and CA Cartwright
Rack1 localizes E-cadherin, b-catenin and p120 catenin, and actin to cell-cell contacts E-cadherin is the major constituent of AJs in epithelial cells and mediates homophilic cell-cell adhesion. At the AJs, E-cadherin in association with b-catenin and p120 catenin is linked to the actin cytoskeleton. We hypothesized that one mechanism by which Rack1 promotes cell-cell adhesion is by regulating the expression levels and/or the localization of E-cadherin and its associated catenins to cell-cell contacts. To test this, we first analyzed the steady-state expression levels of the proteins. We observed that the expression levels of E-cadherin (Figure 3a ), b-catenin ( Figure 3b ) or p120-catenin ( Figure 3c ) were similar in the vector and the wtRk-and mRk-expressing cells. However, when we analyzed the subcellular localization of these proteins by immunofluorescence microscopy ( Figure 2a ), we observed a striking increase in the distribution of E-cadherin, b-catenin and p120 catenin to cell-cell contacts in the wtRk-expressing cells (center panels) as compared with that in control cells (left panels). Moreover, in the contacts of the control cells, E-cadherin Rack1 promotes epithelial cell-cell adhesion G Swaminathan and CA Cartwright appeared to be more disrupted and disorganized than in the contacts of the Rack1-expressing cells. The mRkexpressing cells (right panels) showed increased staining of E-cadherin, b-catenin and p120-catenin at the cell contacts, albeit to a lesser extent than the wtRkexpressing cells.
In a complementary approach to the overexpression studies, we depleted Rack1 in HT-29 cells and analyzed the subcellular distribution of E-cadherin ( Figure 2b ). In Rack1-depleted cells (right panel), we observed less E-cadherin at cell-cell contacts and more diffusely distributed in the cytosol than in control cells (left Figure 3 Rack1 inhibits the tyrosine phosphorylation of E-cadherin and its associated catenins, and the ubiquitination of E-cadherin by disrupting Src-E-cadherin-Hakai interactions. The effect of Rack1 on the tyrosine phosphorylation of the E-cadherin/catenin complex (a-c); the association of E-cadherin, Src and Hakai (d-f); and the ubiquitination and degradation of E-cadherin (g, h). HT-29 transfectants were lysed in 1% NP-40 buffer (a-d), or, to preserve the Hakai-E-cadherin interaction, in 0.3% TX-100 buffer (e, f), or, to detect ubiquitinated E-cadherin, in 1% SDS buffer (g). Lysate protein (0.5-2 mg) was subjected to immunoprecipitation and immunoblot analysis using an antibody that recognizes phospho-tyrosine (PY-20), E-cadherin (120 kDa), b-catenin (95 kDa), p120 catenin (120 kDa), Src (60 kDa), Hakai (55 kDa) or ubiquitin, as indicated. (h) Cells were incubated with cycloheximide (50 mg/ml) alone or together with the lysosomal inhibitors, NH 4 Cl (10 mM) and leupeptin (10 mg/ml), for 4 or 8 h, as indicated. The lysate proteins were subject to immunoblot analysis using an E-cadherin antibody (clone-36). The data shown are representative of three (a-c) or two (d-h) independent experiments. The clones analyzed include vec (G2, G2.2), wtRk (G5, F2.2) and mRk (H8, H11, G12) as shown in panels a-c; and vec (G2.2), wtRk (F2.2) and mRk (H8) as shown in panels d-h. panel). The total levels of E-cadherin were not different in the control and Rack1-depleted cells (Figure 2b , upper panel). These results were consistent with those of the overexpression studies (Figure 2a) .
We next examined Rack1's influence on the localization of actin to cell-cell contacts. Reinforcement of AJs by the actin cytoskeleton is crucial for the maturation and maintenance of the junctions. We observed higher levels of junctional F-actin in the wtRk-expressing cells than in the control cells (Figure 2c , compare the panels in the center and on the left). Moreover, in the wtRkexpressing cells, the pattern of actin staining at the junctions was similar to that of E-cadherin ( Figure 2a) and consistent with stable cell-cell junctions. In control cells, the actin staining at junctions appeared to be more punctate and sporadic, and prominent actin stress fibers were present in the cells. In the mRK-expressing cells, actin localized to both junctions and stress fibers (right panel), indicating an intermediate phenotype. Microtubule localization did not appear to be affected by Rack1 (data not shown).
Collectively, these results suggest that one mechanism by which Rack1 promotes cell-cell adhesion is by localizing E-cadherin, b-catenin, p120-catenin and actin to cell-cell contacts, which stabilizes the junctions. This Rack1 effect appears to be due, in part, to Rack1's inhibitory influence on Src activity.
Rack1 inhibits the tyrosine phosphorylation of E-cadherin, b-catenin and p120 catenin; disrupts the association of E-cadherin with Src and Hakai; and prevents the ubiquitination of E-cadherin Aberrant activation of Src results in increased tyrosine phosphorylation of the E-cadherin/catenin complex, disassembly of cell-cell contacts and increased invasiveness of the cells (Behrens et al., 1993; Owens et al., 2000; Irby and Yeatman, 2002; Frame, 2004) . We tested the hypothesis that one mechanism by which Rack1 promotes cell-cell adhesion in HT-29 cells is by preventing the Src-dependent phosphorylation of E-cadherin, b-catenin and p120-catenin. We observed that expression of wtRk, and to a lesser extent mRk, decreased the tyrosine phosphorylation of E-cadherin (Figure 3a) , b-catenin (Figure 3b ) and p120 catenin (Figure 3c ). Similar results were observed when cells were lysed in radioimmunoprecipitation assay (RIPA) buffer, and when proteins were immunoprecipitated using anti-E-cadherin and immunoblotted with anti-phospho-tyrosine (data not shown). Collectively our results indicate that there are both Src-dependent and -independent mechanisms by which Rack1 downregulates the tyrosine phosphorylation of E-cadherin and its associated catenins in HT-29 cells.
The tyrosine phosphorylation of E-cadherin following either HGF stimulation or expression of active Src enables the recruitment of the ubiquitin ligase Hakai to E-cadherin and the ubiquitination of E-cadherin. This results in E-cadherin endocytosis and its degradation in the lysosomes and subsequent loss of junctional integrity of Madin-Darby canine kidney (MDCK) cells (Fujita et al., 2002; Palacios et al., 2005) . We therefore asked whether Rack1, by inhibiting the tyrosine phosphorylation of E-cadherin, would interfere with E-cadherin's association with Hakai, and subsequently the ubiquitination and degradation of E-cadherin. We observed that expression of wtRk, and to a lesser extent mRk, prevented the association of E-cadherin with Src and Hakai (Figures 3d-f) . The diminished binding of Ecadherin and Hakai was not because of decreased expression of Hakai or E-cadherin, which remained unchanged following Rack1 expression (Figure 3f , lower panels). Consistent with these observations, the ubiquitination of E-cadherin was reduced in cells expressing wild-type, and to a lesser extent, mutant Rack1 (Figure 3g ). To assess the degradation of E-cadherin, cells were treated with cycloheximide for 4 or 8 h prior to lysis (Figure 3h) . The level of a low-molecular-weight (B40 kDa) E-cadherin degradation fragment observed in the vector transfectants (upper left panel, lanes 1-3) was reduced when the cells were pre-treated with lysosomal inhibitors (upper right panel, lanes 10-12), indicating that it was a product of lysosomal degradation. The Rack1-expressing cells (upper left panel, lanes 4-9) had strikingly reduced levels of this fragment when compared with the control cells (lanes 1-3) . Interestingly, similar low-molecular-weight, ubiquitination-dependent lysosomal degradation products of E-cadherin have been described in Src-activated epithelial cells (Palacios et al., 2005) . Taken together, our results show that Rack1 prevents E-cadherin tyrosine phosphorylation, ubiquitination and lysosomal degradation by attenuating the interaction of E-cadherin with Src and Hakai.
Rack1 regulates E-cadherin endocytosis and facilitates the assembly of cell-cell junctions Ubiquitination of E-cadherin by Hakai potentiates the endocytosis of E-cadherin and marks it for degradation, resulting in reduced recycling of E-cadherin to the cell surface (Fujita et al., 2002; Palacios et al., 2005; Shen et al., 2008) . Based on our observations that Rack1 inhibits the tyrosine phosphorylation of E-cadherin (Figure 3a) , disrupts the association of E-cadherin and Hakai (Figure 3f) , and reduces the ubiquitination and degradation of E-cadherin (Figures 3g and h) , we hypothesized that Rack1 regulates the endocytosis of E-cadherin and/or promotes the recycling of E-cadherin to the cell surface, and the re-assembly of cell-cell contacts.
To test this, we first assessed the effect of Rack1 overexpression or deletion on E-cadherin endocytosis. To do so, we labeled E-cadherin on the cell surface (using an E-cadherin antibody, HECD-1, which specifically recognizes the extracellular domain of E-cadherin) at 4 1C and analyzed the internalization of labeled E-cadherin following calcium depletion using EGTA (ethylene glycol-bis (b-aminoethyl ether)-N,N,N 0 ,N 0 ,-tetraacetic acid) at 37 1C. Chelation of extracellular calcium renders E-cadherin association with cell-cell contacts unstable and facilitates E-cadherin endocytosis. We examined both the total amount of E-cadherin (surface and internalized) and the internal pool of labeled E-cadherin (following acid treatment, which removes residual HECD-1 antibody).
Analysis by immunofluorescence microscopy (Figure 4a ) showed that the wtRk-expressing cells (center panels) had strikingly more surface E-cadherin at cell-cell contacts following EGTA treatment, and less internalized E-cadherin following EGTA treatment and acid stripping, than did the control cells (left panels). The mRkexpressing cells contained both surface and internalized E-cadherin (right panels). Nuclear staining using 4,6-diamidino-2-phenylindole (DAPI) indicated the number and the location of EGTA-treated, acidstripped cells in the field. Control experiments showed that incubation with the HECD-1 antibody alone did not induce the internalization of E-cadherin or cause the dissociation of cell-cell contacts (data not shown). These results suggested that Rack1 regulates E-cadherin endocytosis.
Biochemical analyses (Figure 4b) showed that, whereas the total surface levels of E-cadherin (at cellcell contacts and other sites) were not different between the vector-and the Rack1-expressing cells (lanes 2-4), the internalized pool of E-cadherin was markedly reduced in the wtRk-expressing cells (lane-6) and to a lesser extent in the mRK-expressing cells (lane-7) when compared with that in the control cells (lane-5). Cells that were immediately acid-treated following surface labeling of E-cadherin showed no internalized E-cadherin (data not shown), confirming that acid treatment removes all surface E-cadherin antibody.
In contrast to the effects of Rack1 overexpression (Figures 4a and b) , Rack1 depletion induced a striking increase in the internalization of E-cadherin (Figure 4c , right panel) when compared with the control cells (left panel). Co-staining with Rab5 and Rab7 (marker of early and late endosomes, respectively) showed that the internalized pool of E-cadherin was present in both early and late endosomal compartments (Supplementary Figure 2) . Collectively, our results indicate that Rack1 stabilizes E-cadherin at cell-cell contacts in part by regulating the Src-dependent endocytosis of E-cadherin.
The ability of Rack1 to regulate the levels of Ecadherin and catenins at AJs in HT-29 cells suggested an important role for Rack1 in regulating junctional disassembly and/or reassembly. To test this, we performed a calcium switch assay, where cells were cultured in an EGTA-containing medium (Àcalcium) to disassemble cell-cell contacts and then switched to a calciumcontaining medium ( þ calcium) for 1, 2 and 4 h to allow re-formation of contacts ( Figure 5 ). We observed that expression of wtRk (center panels), and to a lesser extent mRk (lower panels), retarded the disassembly of Ecadherin-mediated cell-cell junctions and facilitated their reassembly when compared with the control cells (upper panels). Similar results were obtained with additional clones of vector, wtRk and mRk. These results are consistent with those showing Rack1's promotion of cell-cell adhesion (Figure 1) , localization of E-cadherin and catenins to cell-cell junctions (Figure 2) , and inhibition of E-cadherin endocytosis were incubated for 1 h with an E-cadherin antibody that recognizes the extracellular domain (HECD-1). The cells were left untreated (ÀEGTA) or treated with 1 mM EGTA ( þ EGTA) for 1 h to facilitate E-cadherin endocytosis. The amount of E-cadherin labeled with the HECD-1 antibody in fixed, non-permeabilized, untreated cells (ÀEGTA, row 1), or in fixed, permeabilized, EGTA-treated cells ( þ EGTA, row 2), or in EGTA-treated cells after removal of residual surface antibody by acid stripping ( þ EGTA/AS, row 3), was detected using an Alexa-Fluor-594-conjugated secondary antibody and analyzed by epifluorescence microscopy. Nuclear staining using DAPI in þ EGTA/AS cells was used to demarcate the number and the position of cells (row-4). (b) HT-29 transfectants were incubated with an HECD-1 antibody and treated with EGTA, as outlined in panel a. HECD-1-labeled E-cadherin in untreated cells (ÀEGTA; surface E-cadherin, lanes 2-4) or in EGTA-treated, acid-stripped cells ( þ EGTA/AS; internalized E-cadherin, lanes 5-7) was collected using protein-G agarose following cell lysis and detected by immunoblot analysis using an E-cadherin antibody that recognizes the intracellular domain (clone-36). (c) The localization of HECD-1-labeled E-cadherin in HT-29 cells transfected with a non-targeting siRNA (ctrl si) or Rack1 siRNA (Rk1 si), and treated with EGTA, was assessed as outlined in panel a. The data shown are representative of two or more independent experiments. Rack1 promotes epithelial cell-cell adhesion G Swaminathan and CA Cartwright (Figure 4 ). We also observed that Rack1 localizes to sites of cell-cell contacts where it colocalizes with E-cadherin ( Figure 5 and Supplementary Figure 3) . Immunoprecipitation experiments showed that Rack1 associates with E-cadherin, and with Src in epithelial cells (data not shown). Thus, Rack1 appears to regulate the endocytic trafficking of E-cadherin during junctional remodeling in colon cells.
Rack1 blocks HGF-induced cell scatter by inhibiting E-cadherin endocytosis
The binding of HGF to its receptor c-Met in epithelial cells causes cell-cell dissociation, which is coupled to E-cadherin endocytosis and disruption of cell-cell junctions. This involves E-cadherin tyrosine phosphorylation and recruitment of Hakai, resulting in Ecadherin internalization, similar to the effects observed following expression of active Src (Fujita et al., 2002) .
Src is both a downstream effector and activator of c-Met signaling (Herynk et al., 2007; Emaduddin et al., 2008; Fan et al., 2009; Leroy et al., 2009; Bertotti et al., 2010) . Thus, our findings that Rack1, partly by inhibiting Src, promotes E-cadherin-dependent cell-cell adhesion (Figure 1b) , inhibits matrigel invasion (Figures 1c and  d) and regulates E-cadherin endocytosis (Figure 4 ), prompted us to assess Rack1's influence on HGFstimulated cell scatter and E-cadherin endocytosis. We hypothesized that Rack1, partly by restraining Src activity, blocks HGF-induced cell scatter by inhibiting E-cadherin endocytosis. To test this, we first analyzed HGF-stimulated cell scatter in Rack1-depleted or Rack1-overexpressing HT-29 cells by phase-contrast microscopy. We observed that Rack1-depleted cells scattered more (Figure 6a ) and Rack1-overexpressing cells scattered less (Figure 6b ) than the control cells following HGF stimulation (50 ng/ml; lower panels). Cells expressing wtRk, and to a lesser extent those Figure 5 Rack1 inhibits the disassembly and promotes the reassembly of E-cadherin-containing cell-cell contacts. HT-29 transfectants (vec G2.2, wtRk G5, mRk H11) were incubated in medium containing 1 mM EGTA for 2 h to facilitate the disassembly of E-cadherin contacts (left panels; Àcalcium) followed by incubation in calcium-containing medium for 1, 2 and 4 h to facilitate the reassembly of cell-cell contacts ( þ calcium). The cells were fixed and analyzed for the localization of E-cadherin or GFP-Rack1 as indicated, by epifluorescence microscopy. Representative fields from at least two independent experiments are shown.
Rack1 promotes epithelial cell-cell adhesion G Swaminathan and CA Cartwright expressing mRk, remained as cohesive clusters, whereas the vector-transfected cells showed a more dispersed, motile phenotype (Figure 6b ). These results were consistent with those of the cell aggregation and matrigel invasion studies (Figures 1b and c) .
Next, we analyzed Rack1's effect on E-cadherin localization following HGF stimulation. Consistent with the inhibitory effect of Rack1 on HGF-induced cell scatter, we observed more E-cadherin retained at cell-cell contacts and less internalized in the Rack1-expressing cells than in the control cells following HGF treatment (Figure 6c ). Nuclear staining using DAPI confirmed that the control cells scattered more than the wtRk-or mRK-expressing cells following HGF treatment. Together, these results suggest that an important mechanism by which Rack1 blocks HGF-induced cell scatter is by regulating E-cadherin endocytosis.
To determine whether Rack1 regulates HGF-induced cell scatter in non-tumorigenic epithelial cells, we stably expressed GFP-wtRk or GFP-mRk in MDCK cells ( Figure 6d 
Discussion
In this study, we identify a novel function of Rack1 in promoting epithelial cell-cell adhesion and reducing the invasive properties of colon carcinoma cells by regulating the tyrosine phosphorylation and endocytosis of E-cadherin, and by subverting E-cadherin from degradation to a recycling pathway. The mechanisms by which Rack1 facilitates epithelial cell-cell adhesion and retards the invasion of colon carcinoma cells (Figure 1 ) are by localizing E-cadherin and the associated b-catenin, p120 catenin and actin to cell-cell junctions ( Figure 2) ; inhibiting the tyrosine phosphorylation of the E-cadherin/catenin complex ( Figure 3) ; attenuating the downstream ubiquitination and endocytosis of E-cadherin ( Figures 3g and 4) ; and promoting the re-assembly of cell-cell contacts ( Figure 5 ). Rack1 also blocks HGF-induced cell scattering by inhibiting E-cadherin endocytosis and junctional disassembly ( Figure 6 ). Thus, Rack1 targets both the Src-and growth factor-dependent pathways of E-cadherin endocytosis to promote cell-cell adhesion.
Recent studies identify an important function of Rack1 in regulating the ubiquitination and degradation of proteins. For example, Rack1 is known to compete with HSP90 for binding to hypoxia-inducible factor-1a and is required for the recruitment of Elongin-C/B ubiquitin ligase to mediate the ubiquitination and proteasomal degradation of hypoxia-inducible factor-1a (Liu et al., 2007) . Also, Rack1 targets DNp63 (an Nterminally deleted form of the p53-family member p63) for proteosomal degradation (Fomenkov et al., 2004) . Although the detailed mechanism by which it does so is unknown, it possibly involves an E3 ubiquitin ligase (Fomenkov et al., 2004; Li et al., 2009) . Our results showing that Rack regulates the association of Ecadherin with the E3 ligase Hakai (Figure 3f) , the ubiquitination of E-cadherin by Hakai (Figure 3g ) and the endocytic degradation of E-cadherin (Figures 3h-5 ), together with these other studies, suggest that regulation of the accessibility of ubiquitin ligases to their substrates is an important mechanism by which Rack1 regulates protein degradation.
Emerging evidence indicates that Rack1 regulates the trafficking of cell-surface proteins. For example, Rack1 regulates the distribution of the Na þ /H þ exchanger, NHE6, between endosomes and the plasma membrane, and maintains the luminal pH of the endocytic recycling compartments (Ohgaki et al., 2008) . Rack1 also regulates the transport of the G-protein-coupled receptors for thromboxane-A2, CXCR4 and angiotensin-II type-1 from the endoplasmic reticulum to the cell surface (Parent et al., 2008) . Our results showing that Rack1 regulates the endocytosis and recycling of Ecadherin to the cell surface and cell-cell contacts (Figures 4 and 5) , together with these other studies, identify an important function of Rack1 in regulating the trafficking of cell-surface proteins.
While the effects of Rack1 on junctional homeostasis could be direct or indirect, we find that Rack1 localizes to cell-cell junctions ( Figure 5 and Supplementary  Figure 3) , where, partly through its inhibitory influence on Src, it regulates the tyrosine phosphorylation of the E-cadherin/catenin complexes (Figures 3a-c) , the ubiquitination-dependent endocytosis and lysosomal degradation of E-cadherin (Figures 3 and 4) , and the re-assembly of E-cadherin-containing junctions ( Figure 5 ). An interesting implication from these results and those of others is that Rack1 restrains Src activity at specific subcellular sites where regulated Src activity is needed, thereby providing local 'fine-tuning' or 'checks and balances' on Src activity and substrate function. Examples of these sites include the cell-cell junctions involved in E-cadherin-mediated cell adhesion (Figures  1-6 ; Mourton et al., 2001) , the outer mitochondrial membranes involved in apoptosis (Mamidipudi and Cartwright, 2009) , the inner plasma membrane downstream from receptor tyrosine kinase signaling (Chang et al., 2001 ) and focal adhesions (Cox et al., 2003; Doan and Huttenlocher, 2007) . These studies also suggest that Rack1 forms spatially distinct signaling complexes allowing separation of its regulatory functions.
Our results showing that Rack1's inhibition of Src activity promotes E-cadherin-mediated cell-cell adhesion and inhibits the invasive properties of HT-29 cells (Figure 1 ) are consistent with those of Rengifo-Cam et al. (2004) showing that overexpression of the Src inhibitor carboxylterminal Src kinase (Csk) increases cell-cell adhesion mediated by E-cadherin and decreases the invasive properties of both HT-29 and HCT15 colon carcinoma Figure 6 Rack1 blocks the HGF-induced scatter of epithelial cells by regulating E-cadherin endocytosis. Sub-confluent cultures of Rack1-depleted (a) or Rack1-transfected HT-29 cells (b, c) were serum starved overnight and treated with HGF (50 ng/ml) for 4 h. Rack1-depleted cells (a) were fixed and stained with 0.2% crystal violet and analyzed by phase-contrast microscopy. The HT-29 transfectants (vec G2.2, wtRk G5, mRk H11) were analyzed by phase-contrast microscopy (b) or fixed and stained using an E-cadherin antibody and an Alexa-Fluor-594-conjugated secondary antibody, or stained with DAPI, and analyzed by immunofluorescence microscopy (c). (d) MDCK cells were transfected with pcDNA3-GFP (vector), wild-type Rack1-GFP (wtRk) or Y228F/Y246F Rack1-GFP (mRk). Lysate protein (50 mg) was subjected to immunoblot analysis using anti-Rack1 or -GFP. (e) Sub-confluent MDCK transfectants were treated with HGF (50 ng/ml) for 18 h, prior to fixation and staining, as outlined in panel a. The cells were analyzed at Â 200 magnification except in panel c, where cells were analyzed at Â 400 magnification. Representative fields from two independent experiments are shown.
Rack1 promotes epithelial cell-cell adhesion G Swaminathan and CA Cartwright cells (Rengifo-Cam et al., 2004) . Csk expression resulted in decreased phosphorylation of FAK, but did not affect the localization, expression or phosphorylation of either E-cadherin or b-catenin. Interestingly, we observed that Rack1 overexpression did not affect the tyrosine phosphorylation of FAK (data not shown). Together, these studies suggest that regulation of Src activity, by whatever mechanism, promotes the formation of E-cadherin-mediated cell-cell adhesion. However, Csk appears to regulate Src activity in the integrin pathway, which stabilizes the actin support for the E-cadherin/ b-catenin complex, whereas Rack1 appears to regulate the Src phosphorylation of the E-cadherin/b-catenin complex and E-cadherin stability.
Our mutant studies show that a major mechanism by which Rack1 functions to promote cell-cell adhesion is through its inhibitory influence on Src activity. The Src-dependent component of Rack1 function is most pronounced in the junctional disassembly and reassembly results in Figures 4 and 5 , where the phenotype of the mutant Rack1-expressing cells is closer to that of the control cells than the wild-type, Rack1-expressing cells. However, we also observe a small but reproducible Src-independent mechanism of Rack1 function. Thus, Rack1's effects are only partly because of its ability to inhibit Src. Perhaps Rack1 inhibits other tyrosine kinases from phosphorylating the E-cadherin/catenin complex and/or recruits tyrosine phosphatases to dephosphorylate the complex. Thus, we examined Rack1's influence on protein tyrosine phosphatase m (PTPm), a tyrosine phosphatase that is known to associate with the E-cadherin/ catenin complex (Brady-Kalnay et al., 1995 and with Rack1 (Mourton et al., 2001; Hellberg et al., 2002; Chattopadhyay et al., 2003) . We did not observe changes in PTPm expression or in the association of PTPm with E-cadherin in cells overexpressing Rack1 (data not shown). Additional studies are needed to identify Src-independent mechanisms by which Rack1 facilitates E-cadherinmediated cell-cell adhesion.
In summary, our results suggest that Rack1, by influencing the proximal events in surface E-cadherin trafficking, namely tyrosine phosphorylation and endocytosis of E-cadherin, prevents the disassembly of AJs and subverts E-cadherin from degradation to a recycling pathway. In this way, Rack1 stabilizes cell-cell junctions and reduces the invasive potential of colon cancer cells. Our findings uncover a novel function of Rack1 in regulating the assembly and disassembly of epithelial AJs by restraining the growth factor-and Src-dependent effects on E-cadherin trafficking. The significance of these findings lies in the potential therapeutic application of Rack1 mimetics to inhibit the invasion of colon cancer cells.
Materials and methods
Cell culture and transfections HT-29 and WiDr human colon carcinoma cells and HEK293 human embryonic kidney cells were obtained from ATCC and maintained in an ATCC-recommended medium at 37 1C and 5% CO 2 . The MDCK kidney epithelial cells were provided by Dr James Nelson (Stanford University) and maintained in Dulbecco's modified Eagle's medium (Cellgro, Manassas, VA, USA) containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 1% penicillin-streptomycin (Cellgro) and 50 mg/ml gentamicin (Invitrogen).
To establish HT-29 and MDCK cell lines stably overexpressing Rack1, cells were transfected with the expression vectors pcDNA3-wild-type Rack1-GFP, pcDNA3-Y228/246F Rack1 and pcDNA3-GFP (Mamidipudi et al., 2004 (Mamidipudi et al., , 2007 using Lipofectamine 2000 reagent (Invitrogen), according to the manufacturer's protocol. The transfected cells were selected with 1 mg/ml G418 (Cellgro) and stable lines were maintained in 200 mg/ml G418. The MDCK stable lines were further enriched for GFP-expressing population by cell sorting (FACS Vantage, BD Biosciences, San Jose, CA, USA). HT-29 stable cell lines were purified by serial dilutions and single-cell clones were expanded.
To deplete endogenous Rack1, HT-29 and WiDr cells were transfected with an On-Target plus SMARTpool small interfering RNA (siRNA) for GNB2L1 (Rack1) or a control non-targeting siRNA (Dharmacon, Lafayette, CO, USA) using the Dharmafect transfection reagent. The cells were harvested at 48 or 72 h, as indicated.
For cycloheximide chase assays, HT-29 stable transfectants were incubated with cycloheximide (50 mg/ml; Sigma, St Louis, MO, USA) to inhibit protein translation for 4 or 8 h.
In control experiments, the lysosomal inhibitors ammonium chloride (NH 4 Cl, 10 mM) and leupeptin (10 mg/ml) were added.
Cell lysis and immunoblot analyses
Preparation of cell lysates and immunoblot analysis were performed as described by Chang et al. (2002) and Mamidipudi et al. (2007) , with modifications. Briefly, cells grown to B70-80% confluence were lysed with 0.5-1% NP-40 lysis buffer (containing protease inhibitors (Sigma, P8340), 1.5 mM phenylmethylsulfonate, 0.5 mM sodium orthovanadate and 1 mM sodium fluoride (Sigma)) directly on the plate, transferred to Eppendorf tubes and rotated for 20 min. The lysates were cleared by centrifugation at 13 000 r.p.m. and protein estimation was performed using the Bradford assay reagent (Bio-Rad Laboratories, Hercules, CA, USA). Equal amount of protein was analyzed by immunoblotting using appropriate antibodies: E-cadherin clone-36, b-catenin, p120 catenin, FAK, Rack1, phospho-tyrosine (BD Biosciences); E-cadherin clone HECD-1 (Calbiochem, La Jolla, CA, USA); E-cadherin clone H108, Hakai, Rack1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); Src mAb327 (Lipsich et al., 1983) ; GFP (BD Biosciences); actin, a-tubulin (Sigma); and phosphotyrosine clone-4G10 (Upstate, Lake Placid, NY, USA). The primary antibodies were detected using horseradish peroxidaselabeled secondary antibodies (Bio-Rad) and ECL chemiluminescence (Pierce or Thermo Fisher Scientific, Rockford, IL, USA). Images were scanned (HP Scanjet), converted to gray mode in Photoshop and quantitated using the ImageJ software (NIH, Bethesda, MD, USA).
Immunoprecipitations
For immunoprecipitation experiments, 4 Â 10 6 cells were cultured in a 10-cm tissue culture dish for 48 h. The cells were washed with phosphate-buffered saline (PBS) and lysed in a plate with 400-500 ml of cold NP-40 or RIPA buffer, or 0.3% TX-100 (Chang et al., 2002; Fujita et al., 2002) , as indicated. The lysates were transferred to 1.5-ml tubes, rotated for 20 min and clarified by centrifugation at 13 000 r.p.m. for 30 min. The supernatants (500 mg to 2 mg total protein) were incubated using the appropriate primary antibodies for 1-2 h at 4 1C. A 20-ml volume of protein-A or protein-G agarose beads (Invitrogen) was added and the tubes were rotated at 4 1C for 1-2 h or overnight. The beads were washed thrice with lysis buffer, once with Tris-buffered saline and resuspended in sodium dodecyl sulfate loading buffer (Invitrogen). The samples were boiled for 5 min at 95 1C and centrifuged briefly. The supernatants were resolved on 4-12% Bis-Tris gels (Invitrogen), transferred to polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA) and probed using appropriate primary antibodies.
To detect ubiquitination of E-cadherin, the cells were lysed in 1% TX-100 lysis buffer containing 1% SDS, boiled for 10 min at 95 1C and sonicated (Fujita et al., 2002; Varghese et al., 2008) . The lysates were diluted 10-fold with 1% TX-100 lysis buffer and pre-cleared with 20 ml of protein-A/G agarose beads prior to immunoprecipitation using E-cadherin antibody. The beads were washed sequentially with 1% TX-100 buffer containing 0.5 M NaCl, 1% TX-100 buffer with 0.1% SDS, 1% TX-100 buffer and Tris-buffered saline, and analyzed by immunoblotting as described above. Ubiquitinated E-cadherin was detected using a ubiquitin antibody (clone FK2; Biomol, Plymouth Meeting, PA, USA).
Hanging-drop assay
The assay was performed as described by Kim et al. (2000) , with few modifications. Briefly, HT-29 cells grown at low density were trypsinized, centrifuged and resuspended as single-cell suspensions at a cell density of 0.5 Â 10 6 cells/ml in medium with or without 2 mM EDTA (Sigma). Twentymicroliter drops of the suspension were seeded onto the inner surface of 35-mm tissue culture dish lids. The lids were then inverted and placed on the dishes so that the drops were hanging from the lid. The dishes were filled with 2 ml of PBS to prevent evaporation. After incubation for 20 h at 37 1C, the lids were inverted and the drops titurated 10 times through a 200-ml Gilson pipette tip. Phase-contrast images of cell clusters were obtained before and after pipetting using a Nikon Eclipse microscope at Â 100 magnification. The area of cell clusters was determined using the ImageJ software (NIH). The area occupied by different size clusters (ranging from 2 cells to 41700 cells per cluster) was measured in pixel units. The area occupied by single cells was measured in parallel to estimate the amount of cells per area unit. The data were quantified based on the area of the aggregate and the approximate number of cells per aggregate.
Matrigel invasion assay
Transwell polycarbonate filters with 8-mm pore size (Corning, Lowell, MA, USA) were coated with 1 mg/ml growth factorreduced matrigel (BD Biosciences) for 2 h at 37 1C. Sub-confluent cells were trypsinized, washed with serum-free medium and resuspended in serum-free medium containing 0.1% bovine serum albumin. A total of 3 Â 10 4 cells were added to the coated filters and incubated in 24-well plates for 48 h. Medium containing 10% serum was added to the wells to serve as chemoattractant. The filters were fixed with methanol and stained with 0.2% crystal violet (Alfa Aesar, Ward Hill, MA, USA). Cells on the upper surface of the filters were removed by wiping with a cotton swab and cells that had invaded through the matrigel to the lower (chemoattractant) side of the filter were counted at Â 200 magnification. All cells on the filter were counted.
Immunofluorescence microcopy
Cells were cultured overnight in eight-well Labtek chamber slides (Nunc, Rochester, NY, USA) at 5 Â 10 4 cells/well in a 10% FBS-containing medium. The cells were washed with PBS and fixed in 4% paraformaldehyde for 20 min (Mamidipudi et al., 2004) . The cells were washed with PBS containing 0.1% glycine followed by blocking with PBS containing 10% serum. Primary antibodies were diluted in blocking buffer (E-cadherin clone-36 (2.5 mg/ml), b-catenin (0.5 mg/ml), p120 catenin (0.5 mg/ml) (BD Biosciences); rhodamine-phalloidin (1.5 U/ml; Molecular Probes, Carlsbad, CA, USA); a-tubulin (Sigma); E-cadherin HECD-1 (2 mg/ml; Calbiochem); Rab5 C851 (1:100; Cell Signaling Technology, Danvers, MA, USA); Rab7 D95F2 (1:150; Cell Signaling Technology)) and incubated with the cells for 1 h at 25 1C or overnight at 4 1C, as indicated. The cells were washed with 0.1% TX-100-PBS buffer and incubated with secondary antibody labeled with Alexa-Fluor-594 or 546 or 649 (Molecular Probes) for 30 min at 25 1C. The cells were washed and mounted with Vecta-shield containing 0.1 mg/ml DAPI (Vector Labs, Burlingame, CA, USA). Twelve-bit or 8-bit gray images were captured using a Nikon Eclipse E600 epifluorescence or a Nikon Eclipse Ti confocal or a Nikon E800 confocal microscope using a Â 40, objective using the SPOT advanced or NIS Elements software or the Simple PCI software. The images were transferred to Photoshop (version CS4; Adobe) for resizing, labeling, pseudo-coloring and adjustments in bright/dark contrast.
E-cadherin internalization
Cells were cultured in eight-well chamber slides (5 Â 10 4 ) or 35-mm tissue culture dishes (5 Â 10 5 ), as indicated. The cells were washed with PBS, incubated on ice for 1 h with HECD-1 (an antibody that specifically recognizes the extracellular domain of E-cadherin; 2 mg/ml) and washed several times with PBS to remove unbound antibody. To disrupt E-cadherin homophilic interactions and to facilitate E-cadherin internalization, cells were incubated in medium containing 1 mM EGTA (calciumdepleted medium) at 37 1C for 1 h. To remove the HECD-1 bound to the E-cadherin remaining on the surface, the cells were washed on ice with buffer containing 0.5 M CH 3 COOH and 0.5 M NaCl (acid stripping). Untreated cells and cells treated with EGTA with or without acid stripping were fixed for immunofluorescence. HECD-1-labeled E-cadherin in untreated, fixed, non-permeabilized cells (total surface E-cadherin) and in permeabilized, EGTA-treated cells before acid stripping (surface and internalized E-cadherin) and after acid stripping (internalized E-cadherin) was detected by immunofluorescence microscopy using anti-mouse Alexa-Flour-594 antibody against HECD-1.
For biochemical analyses, frozen pellets of untreated cells and EGTA-treated, acid stripped cells were lysed with 1% NP-40 buffer. HECD-1-labeled E-cadherin was collected using protein-G agarose (20 ml; Invitrogen) and detected by immunoblotting using an E-cadherin antibody (clone-36).
The following control experiments were performed: (1) To estimate the total amount of HECD-1-labeled E-cadherin on the cell surface, cells were fixed for immunofluorescence or frozen as pellets for biochemical analysis immediately following labeling and washing; (2) to ensure complete stripping of surface HECD-1 and to avoid possible contamination of the internal signal, the labeled cells were immediately subject to acid stripping and fixed or frozen prior to analysis, and (3) as a negative control, the cells were incubated in PBS without HECD-1.
For analyzing junctional disassembly and reassembly, cells (5 Â 10 4 ) cultured overnight in eight-well chamber slides were either left untreated (control) or treated with 1 mM EGTAcontaining medium for 2 h at 37 1C (which depletes calcium and facilitates disassembly), or treated with EGTA for 2 h followed by incubation in calcium-containing medium for 1, 2 and 4 h at 37 1C (promotes reassembly). The cells were fixed and stained using an E-cadherin antibody, as described above.
Cell scatter analysis
To analyze the scattering of HT-29 cells, 5 Â 10 4 cells were plated in a 24-well tissue culture dish for 24 h at 37 1C. The cells were serum-starved overnight and then stimulated with 50 ng/ml HGF (or left unstimulated) for 90 or 240 min. Following HGF stimulation, the cells were analyzed by phase-contrast microscopy in culture or following methanol fixation and staining with 0.2% crystal violet. Phase-contrast images were captured at Â 200 magnification using a Nikon Eclipse confocal microscope and the NIS-Elements software.
To examine E-cadherin endocytosis during HGF-induced cell scattering, cells were plated in eight-well chamber slides, treated with HGF, fixed and stained using an anti-E-cadherin antibody, as described above. To analyze the scattering of MDCK cells, 2 Â 10 4 cells were cultured in 24-well tissue culture dish for 48 h and treated with 50 ng/ml HGF overnight at 37 1C.
